
NICE is still working out what its role with the new NHS Commissioning Board will be, with other key issues …
Amphista doses first patient in AML trial of protein degrader
Jennings becomes President of Beckman Coulter Diagnostics
Boyds expands Regulatory Affairs team to support growing demand

